☆ 4.5 Letter

Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL

BONE MARROW TRANSPLANTATION (2013)

期刊

BONE MARROW TRANSPLANTATION

卷 48, 期 5, 页码 740-741

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/bmt.2012.207

关键词

-

类别

Biophysics Oncology Hematology Immunology Transplantation

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Cell & Tissue Engineering

Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan

Uzma Zaidi, Mushkbar Fatima, Shafaq Abdul Samad, Kashif Shafique, Hira Fatima Waseem, Tasneem Farzana, Tahir Sultan Shamsi

Summary: This study analyzes the success of allogeneic hematopoietic stem cell transplant in aplastic anemia patients. The findings suggest that the Flu/Cy conditioning regimen can be a suitable alternative for developing countries with limited healthcare resources.

STEM CELLS INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation

Laurel Truscott, Holly Pariury, Santosh Hanmod, Monica Davini, Michelina de la Maza, Lauren N. Sapp, Kyleigh Staples, Maria Proytcheva, Emmanuel Katsanis

Summary: This study presents a 10-year experience of consecutive allo-HCT in pediatric patients with high-risk myeloid malignancies. The results demonstrate that BU-FLU-MEL conditioning is effective for disease control in young patients undergoing allo-HCT, but using PBSC grafts with CSA-MTX as GvHD prophylaxis leads to an unacceptably high incidence of GvHD.

PEDIATRIC BLOOD & CANCER (2023)

添加到收藏夹

Article Hematology

A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors-A single-centre, prospective, explorative study

Yunsuk Choi, Eun-Ji Choi, Han-Seung Park, Jung-Hee Lee, Je-Hwan Lee, Young-Shin Lee, Young-A Kang, Mijin Jeon, Ji Min Woo, Hyeran Kang, Seunghyun Baek, Su Mi Kim, Chae-Eun Bong, Kyoo-Hyung Lee

Summary: In this study evaluating the outcome of hematopoietic cell transplantations (HCT) in acute myeloid leukemia (AML) patients, the differences in donor sources (haploidentical family, matched sibling, and unrelated donors) were examined. The results showed that haploidentical family donors had a significantly higher incidence of acute graft-versus-host disease (GVHD), as well as a higher likelihood of complete donor chimerism in peripheral mononuclear cells. However, there were no significant differences in other outcomes such as engraftment, chronic GVHD, leukemia recurrence, non-relapse mortality, and patient survival.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Biophysics

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

Ali Bazarbachi, Myriam Labopin, Didier Blaise, Edouard Forcade, Gerard Socie, Ana Berceanu, Emanuele Angelucci, Claude Eric Bulabois, Nicolaus Kroeger, Alessandro Rambaldi, Patrice Ceballos, Stephan Mielke, Jean El Cheikh, Ibrahim Yakoub-Agha, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad Mohty

Summary: The study compared the outcomes of haploidentical allogeneic hematopoietic-cell transplantation and matched unrelated donor transplantation for AML patients in different risk groups and remission statuses. The results showed that haploidentical transplantation increased nonrelapse mortality and decreased relapse incidence in high-risk AML in CR, leading to similar leukemia-free survival, overall survival, and graft-versus-host disease-free, relapse-free survival compared to matched unrelated donor transplantation. This suggests the potential benefits of using haploidentical family donors for high-risk AML patients without matched sibling donors.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Article Biophysics

Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation

Marjan Cruijsen, Jacobien R. Hilberink, Walter J. F. M. van der Velden, Joop H. Jansen, Brigitte Bar, Nicolaas P. M. Schaap, Anton de Haan, Andre B. Mulder, Marco R. de Groot, Frederic Baron, Edo Vellenga, Nicole N. M. Blijlevens, Gerwin Huls

Summary: The combination of decitabine with a standard non-myeloablative conditioning regimen prior to allogeneic hematopoietic cell transplantation can effectively reduce relapse incidence in poor risk AML patients. The study demonstrated a one-year relapse rate of 23% and a one-year overall survival of 70% in this patient population.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Article Biophysics

Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Jun Aoki

Summary: Myeloablative conditioning with Fludarabine/Busulfan (Flu/Bu4) and busulfan/cyclophosphamide (Bu4/Cy) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) showed similar outcomes in MDS patients, with no patients having a favorable overall survival rate in either group.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Article Oncology

Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation

Takaaki Konuma, Junya Kanda, Naoyuki Uchida, Akihiko Nishijima, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Makoto Onizuka, Shuichi Ota, Yumiko Maruyama, Yoshinobu Kanda, Toshiro Kawakita, Takahide Ara, Tetsuya Eto, Hirohisa Nakamae, Takafumi Kimura, Takahiro Fukuda, Yoshiko Atsuta

Summary: The impact of conditioning intensity on different donor groups in allogeneic transplantation was examined, and it was found that intensified conditioning improved disease-free survival and relapse rate for unrelated single-cord blood transplants, but had no significant effect on sibling donor and unrelated donor transplants.

HEMATOLOGICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors

Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Sherif M. Badawy, Amer Beitinjaneh, Chris Bredeson, Jean-Yves Cahn, Jan Cerny, Miguel Angel Diaz Perez, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Usama Gergis, Gerhard C. Hildebrandt, Michael R. Grunwald, Shahrukh Hashmi, Nasheed M. Hossain, Matt Kalaycio, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Betty Ky Hamilton, Hillard M. Lazarus, Jane Liesveld, Mark Litzow, David Marks, Hemant S. Murthy, Sunita Nathan, Aziz Nazha, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Bipin Savani, Sachiko Seo, Melhem Solh, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, Ravi Vij, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber

Summary: This retrospective cohort study of 1761 adult patients aged 50 and older with myelodysplastic syndrome found that using younger unrelated donors for allogeneic hematopoietic cell transplantation resulted in higher disease-free survival and lower relapse rates compared to using older sibling donors.

JAMA ONCOLOGY (2022)

添加到收藏夹

Article Hematology

Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation

Dipenkumar Modi, Jie Chi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti

Summary: The study showed that the Flu-Mel140-TBI regimen is feasible and provides durable disease control in allogeneic hematopoietic stem cell transplantation with HLA-matched donors. Although the addition of TBI did not significantly improve outcomes, older age and prior transplants in some patients could result in higher NRM.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

添加到收藏夹

Article Hematology

Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia

Riad El Fakih, Saud Alhayli, Syed Osman Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Amr Hanbali, Feras Alfraih, Alfadel Alshaibani, Ali Assiri, Hadeel Samarkandi, Fatima Babiker, Ahmad Alshomar, Anas Alhakim, Emad Ghabashi, Ahmed Kotb, Tusneem Elhassan, Ahmed Balbaid, Husam Alsadi, Walid Rasheed, Ali Alahmari, Hazzaa Alzahrani, Fahad Almohareb, Mahmoud Aljurf

Summary: This study is a retrospective analysis of 82 consecutive patients with severe aplastic anemia who underwent allogeneic hematopoietic cell transplantation with a matched sibling donor. The results show that using mobilized bone marrow grafts and fludarabine-cyclophosphamide conditioning is an effective and safe approach for treating these patients.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

添加到收藏夹

Article Oncology

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

Raynier Devillier, Boris Calmels, Sophie Guia, Mohammed Taha, Cyril Fauriat, Bechara Mfarrej, Geoffroy Venton, Eric Vivier, Daniel Olive, Christian Chabannon, Didier Blaise, Sophie Ugolini

Summary: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective curative option for high-risk hematologic malignancies, but disease recurrence remains a critical issue. NK cell-based immunotherapies offer a promising approach to enhance anti-tumor effects without triggering graft-versus-host disease. This clinical trial demonstrates the safety and potential efficacy of prophylactic donor-derived IL-2 activated NK cell infusion after allo-HSCT for patients with hematologic malignancies.

CANCERS (2021)

添加到收藏夹

Article Hematology

Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis

Akanksha Chichra, Lingaraj Nayak, Rushabh Kothari, Siddhesh Kalantri, Avinash Bonda, Anant Gokarn, Sachin Punatar, Sumeet Mirgh, Nishant Jindal, Bhausaheb Bagal, Sadhana Kannan, Libin Mathew, Navin Khattry

Summary: This study compares the toxicity and outcomes of two reduced-intensity conditioning regimens, Flu-Mel and Flu-Treo, in different donor groups for transplantation. The results show that Flu-Treo has lower toxicity in terms of severe mucositis and diarrhea compared to Flu-Mel. Additionally, Flu-Treo provides comparable outcomes to Flu-Mel in all donor transplants.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2023)

添加到收藏夹

Article Hematology

Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis

Krischan Braitsch, Alix Schwarz, Katrin Koch, Mara Hubbuch, Helge Menzel, Ulrich Keller, Katharina S. Goetze, Florian Bassermann, Peter Herhaus, Mareike Verbeek

Summary: This retrospective analysis compares the efficacy and tolerability of reduced intensity conditioning regimens, Flu/Treo and FLAMSA-RIC, in patients with myeloid malignancies undergoing alloSCT. The results indicate that there is no significant difference in engraftment, survival, relapse, transplant-related mortality, and graft-versus-host disease between the two regimens.

ANNALS OF HEMATOLOGY (2022)

添加到收藏夹

Article Hematology

Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation

Naveed Ali, Ashish Arunkumar Sharma, Ana Carolina Pires de Rezende, Folashade Otegbeye, Bilal Muhammad Latif, Mariana Nassif Kerbauy, Brenda W. Cooper, Gabriela Sanchez, Leland Metheny, Saswat K. Bal, Roberto Sakuraba, Benjamin K. Tomlinson, Kirsten M. Boughan, Lucila Kerbauy, Ehsan Malek, Andreza Feitosa Ribeiro, Molly Gallogly, David Mansur, Gisele Pereira, Eduardo Weltman, Rafick-Pierre Sekaly, Marcos de Lima, Paolo F. Caimi, Nelson Hamerschlak

Summary: This study evaluated the efficacy of intensified fludarabine/busulfan (Flu/Bu) reduced-intensity conditioning (RIC) regimen with targeted marrow irradiation (TMI) in high-risk hematologic malignancies patients. The results showed that this approach was feasible with low transplantation-related mortality in medically frail patients with advanced malignancies.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

添加到收藏夹

Article Biophysics

Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Juergen Finke, Claudia Schmoor, Matthias Stelljes, Andreas Burchert, Peter Dreger, Ute Hegenbart, Eva-Maria Wagner-Drouet, Martin Bornhaeuser, Kristina Sohlbach, Natalie Schub, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, Olga Grishina

Summary: This study aimed to investigate the efficacy of a second allogeneic HCT using Thiotepa, Fludarabine, and Treosulfan (TFT) as conditioning therapy in patients with AML relapse > 6 months after the first allogeneic HCT. The results showed that this approach is feasible and has a high anti-leukemic efficacy, but relapse rates and non-relapse mortality remain a challenge.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Review Oncology

Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations

Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow, Alexander Kiani, Manuela Krumbholz, Maaike Luesink, Nora Naumann-Bartsch, Barbara De Moerloose, Michael Osborn, Kirk R. Schultz, Petr Sedlacek, Fiorina Giona, Christian Michel Zwaan, Hiroyuki Shimada, Birgitta Versluijs, Frederic Millot, Nobuko Hijiya, Meinolf Suttorp, Markus Metzler

Summary: The treatment of chronic myeloid leukemia has improved with the use of tyrosine kinase inhibitors; however, the prognosis for CML in the blast phase remains poor and treatment options are limited. In order to provide consistent therapy for children and adolescents with this high-risk disease, an international panel of pediatric CML experts developed recommendations based on current literature and national standards.

LEUKEMIA (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study

Piotr Lacina, Rachel E. Crossland, Joanna Wielinska, Anna Czyz, Agnieszka Szeremet, Marek Ussowicz, Tomasz Wrobel, Anne M. Dickinson, Katarzyna Bogunia-Kubik

Summary: This study aimed to identify biomarkers associated with the occurrence of cGvHD by analyzing miRNAs in plasma EVs. The results revealed that hsa-miR-630 and hsa-miR-374b-5p were downregulated in cGvHD patients, while hsa-miR-29c-3p was upregulated.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2023)

添加到收藏夹

Article Immunology

National experience with adenosine deaminase deficiency related SCID in Polish children

Nel Dabrowska-Leonik, Barbara Piatosa, Ewa Slominska, Nadezda Bohynikova, Katarzyna Bernat-Sitarz, Ewa Bernatowska, Beata Wolska-Kusnierz, Krzysztof Kalwak, Sylwia Koltan, Anna Dabrowska, Jolanta Gozdzik, Marek Ussowicz, Malgorzata Pac

Summary: This study retrospectively evaluated the clinical course and test results of 7 patients diagnosed with ADA deficiency in Poland from 2010 to 2022. The patients demonstrated immune and non-immune symptoms, and 5 of them underwent hematopoietic stem cell transplantation. Early diagnosis is crucial to prevent irreversible multi-organ failure.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience

Jagoda Siemaszko, Marek Ussowicz, Blanka Rybka, Renata Ryczan-Krawczyk, Krzysztof Kalwak, Katarzyna Bogunia-Kubik

Summary: This study investigated the impact of NKG2 receptors and their ligands polymorphisms on post-transplant complications after haematopoietic stem cell transplantation (HSCT) in children. The HLA-E rs1264457 polymorphism was significantly associated with cytomegalovirus (CMV) infection. NKG2A or MICA polymorphisms showed a strong trend towards the risk of acute graft-versus-host disease (GvHD). These findings suggest that genotyping results may have prognostic value for the outcome of paediatric HSCT.

FRONTIERS IN GENETICS (2023)

添加到收藏夹

Article Oncology

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification

Aleksandra Wieczorek, Katarzyna Szewczyk, Tomasz Klekawka, Joanna Stefanowicz, Marek Ussowicz, Grazyna Drabik, Katarzyna Pawinska-Wasikowska, Walentyna Balwierz

Summary: Patients with stage 3 neuroblastoma without MYCN amplification show heterogeneity in disease presentation and prognosis. Age at diagnosis, INPC diagnostic category, chromosomal aberrations, and biochemical markers are prognostic factors. The risk of treatment failure is higher in patients with segmental chromosomal aberrations, especially in those over 18 months, and may require more intensive treatment.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Microbiology

Quantitative and Qualitative Airborne Mycobiota Surveillance in High-Risk Hospital Environment

Aleksandra Gorzynska, Aneta Grzech, Paulina Mierzwiak, Marek Ussowicz, Monika Biernat, Urszula Nawrot

Summary: The primary aim of this study was to assess the prevalence of fungi in selected hospital wards and evaluate the susceptibility of Aspergillus fumigatus isolates to triazoles. Air samples were collected and cultured on Sabouraud agar. The study found that protected rooms with sterile air circulation and air disinfection devices had significantly lower amounts of cultured fungi compared to unprotected rooms. The most contaminated areas were corridors and bathrooms, with Cladosporium and Penicillium being the dominant species. A rare outbreak of A. fumigatus spores was noted in a hospital for lung diseases but no triazole-resistant isolates were detected. Regular microbiological testing of the hospital environment can help detect spore outbreaks and enable corrective procedures.

MICROORGANISMS (2023)

添加到收藏夹

Article Pediatrics

Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Pawel Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar

Summary: Venetoclax has shown significant clinical activity in relapsed or refractory leukemias in paediatric patients in Poland. Although not currently incorporated into paediatric treatment schedules, it has been used in patients who have failed conventional therapy. This study aims to gather clinical data and correlates of paediatric patients treated with Venetoclax to guide its clinical use and stimulate further research.

CHILDREN-BASEL (2023)

添加到收藏夹

Article Oncology

Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study

Zuzanna Nowicka, Bartlomiej Tomasik, David Kozono, Konrad Stawiski, Thomas Johnson, Daphne Haas-Kogan, Marek Ussowicz, Dipanjan Chowdhury, Wojciech Fendler

Summary: The study demonstrates that serum miRNAs can be used as functional biodosimeters to predict the biological impact of radiation doses in humans undergoing total body irradiation. A logistic regression model was built using miR-150-5p, miR-30b-5p, and miR-320c, which showed high accuracy in identifying samples drawn after irradiation.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings-Real-World Data

Aleksandra Wieczorek, Urszula Zebrowska, Marek Ussowicz, Agnieszka Sokol, Marzena Stypinska, Bozenna Dembowska-Baginska, Katarzyna Pawinska-Wasikowska, Walentyna Balwierz, Giuseppina Barutello

Summary: A retrospective study conducted in Poland demonstrated the feasibility and benefits of using Dinutuximab beta for maintenance treatment in patients with high-risk neuroblastoma. The overall survival and progression-free survival rates were high, and the treatment was generally well tolerated.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Review Medicine, General & Internal

Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia

Beata Sienkiewicz-Oleszkiewicz, Malgorzata Salamonowicz-Bodzioch, Justyna Slonka, Krzysztof Kalwak

Summary: The interaction between antifungal drugs and common drugs is an important issue in pediatric hemato-oncology. This review focuses on the interaction between antifungal agents and treatment drugs for acute lymphoblastic leukemia, and found that liposomal amphotericin B has a favorable safety profile.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Review Medicine, General & Internal

Priapism at Diagnosis of Pediatric Chronic Myeloid Leukemia: Data Derived from a Large Cohort of Children and Teenagers and a Narrative Review on Priapism Management

Meinolf Suttorp, Stephanie Sembill, Krzysztof Kalwak, Markus Metzler, Frederic Millot

Summary: Pediatric chronic myeloid leukemia (CML) is a rare malignancy with priapism observed in approximately 3.2% of boys with pediatric CML. Priapism duration varied from hours to months, with intermittent priapism being the most common presentation. All patients exhibited splenomegaly and massive leukocytosis. Interventions for priapism included intravenous fluids, heparin, penile puncture, sympathomimetics, and surgical shunt operations. Long-term survivors responded well to treatment and maintained full erectile function.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Oncology

Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia-Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022

Malgorzata Czogala, Wojciech Czogala, Katarzyna Pawinska-Wasikowska, Teofila Ksiazek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawel Laguna, Anna Falkowska, Katarzyna Drabko, Katarzyna Muszynska-Roslan, Maryna Krawczuk-Rybak, Marta Kozlowska, Ninela Irga-Jaworska, Karolina Zielezinska, Tomasz Urasinski, Natalia Bartoszewicz, Jan Styczynski, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Krzysztof Kalwak, Malgorzata Ciebiera, Radoslaw Chaber, Agnieszka Mizia-Malarz, Agnieszka Chodala-Grzywacz, Grazyna Karolczyk, Katarzyna Bobeff, Wojciech Mlynarski, Katarzyna Mycko, Wanda Badowska, Renata Tomaszewska, Tomasz Szczepanski, Katarzyna Machnik, Natalia Zamorska, Walentyna Balwierz, Szymon Skoczen

Summary: Mutations in the FLT3 gene are associated with poor outcomes in pediatric AML. A retrospective analysis of a nationwide pediatric AML database showed that FLT3-ITD-positive patients had worse survival compared to FLT3-ITD-negative patients. Treatment protocols and the use of FLT3 inhibitors and stem cell transplantation showed potential for improving outcomes. Additional genetic mutations, such as WT1 and NPM1, significantly influenced prognosis.

CANCERS (2023)

添加到收藏夹

Article Oncology

Physical Activity Level and Quality of Life of Children Treated for Malignancy, Depending on Their Place of Residence: Poland vs. the Czech Republic: An Observational Study

Aleksandra Kowaluk, Katarzyna Siewierska, Marie Choniawkova, Petr Sedlacek, Krzysztof Kalwak, Iwona Malicka

Summary: This study aimed to assess the level of physical activity (PA) and quality of life of cancer-treated children, depending on their place of residence (Poland vs. the Czech Republic, where incidence and mortality rates of childhood malignancies are similar). The study showed significant differences in PA levels between Polish and Czech children. Physically active children engaging in more frequent PA reported higher physical performance, higher energy levels, and less mood disturbance. Our study emphasized the importance of promoting tailored PA programs for cancer-treated children to improve well-being and quality of life.

CANCERS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.